Health Canada approves Precision Biomonitoring’s rapid SARS-CoV-2 testing device
by CM Staff
The TRIPLELOCK Test Strips deliver COVID-19 results within 60 minutes, according to company statement
GUELPH, Ont. — Precision Biomonitoring announced it has received Health Canada approval for its ready-to-use thermostable SARS-CoV-2 TRIPLELOCK Test Strips for use across Canada.
The TRIPLELOCK™ Test Strips are a rapid diagnostic RT-PCR test able to provide accurate results for 9 samples in 60 minutes. Precision Biomonitoring previously announced in June that it received approval and funding from Next Generation Manufacturing Canada (NGen) to support manufacturing of its ready-to-use thermostable test.
“We are proud to be adding another Health Canada approval to the list of testing devices offered by Precision Biomonitoring. We have been working closely with various industries across Canada to help bring their workforce back safely, and are thrilled to be expanding that capability,” said Mario Thomas, CEO, Precision Biomonitoring, in a prepared statement. “This approval also means we can strengthen our ongoing support for federal and provincial governments, as well as Canadian industries.”
The SARS-CoV-2 TRIPLELOCK Test Strips are designed for RT-PCR point-of-need diagnostics and are stable at room temperature.
Precision Biomonitoring also recently received CE Mark approval in Europe for its TRIPLELOCK SARS-CoV-2 test in 96-Well Plate format.
